Updates from Oxford Astrazeneca Covid vaccine safety briefing

The UK’s Deputy Head Physician Professor Jonathan Van-Tam is holding a briefing with the UK Medicines Agency following an Oxford / AstraZeneca vaccine investigation and possible links to blood clots.

The televised media briefing begins at 3 p.m. At the same time, the European Medicines Agency (EMA) is offering an update on whether it is of the opinion that there is a causal link between the bite and rare blood clots.

We will be broadcasting the briefing live and reporting key lines and announcements as they are made.

Scroll down for the latest updates.

To Prof. Van-Tam come Dr. June Raine, Executive Director of the Medicines and Health Products Regulatory Authority (MHRA), Professor Sir Munir Pirmohamed, Chairman of the Medicines Commission for Human Use, and Professor Wei Shen, Chairman of the Joint Vaccination and Immunization Committee (JCVI).

Both the EMA and MHRA have been reviewing reports of rare brain clots in people who have received the AstraZeneca vaccine.

It comes after Bristol University Professor Adam Finn and a member of the JCVI said it was important to keep the vaccination program going as society opened up to stave off rising infection rates.

Some European countries have restricted vaccine use in younger people following reports of low platelet counts and cerebral venous sinus thrombosis (CVST), a type of clot that prevents blood from draining from the brain.


Leave a Comment